Hypertelmival 40 mg (Telmisartan)

Adult dose

1. Essential Hypertension Telmisartan should be taken orally at a dose of 40 mg once daily with water, regardless of meals. Depending on the patient, 20 mg once daily may also be effective. If necessary, the dose can be increased up to 80 mg once daily. Dose increases will show maximum blood pressure-lowering effects 4 to 8 weeks after starting treatment. 2. Reduction of cardiovascular disease risk As this medication

This medication can cause serious harm or risk of death to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. It should not be used in patients with allergic reactions, severely impaired liver function, pregnant or breastfeeding women, or patients with certain kidney diseases. Elderly patients or those with reduced kidney function, as well as patients with heart or vascular problems, should use this medication with caution and monitor their condition closely. Upon taking this medication, blood pressure may drop too low, or dizziness, fainting, etc. may occur, so if these symptoms appear, immediate consultation with medical staff is necessary. There is a risk of increased potassium levels in the blood, so patients at risk of hyperkalemia should have regular blood tests for monitoring. It can affect liver or kidney function, so periodic liver and kidney function tests are important during treatment. This medication may interact with other antihypertensives, diuretics, lithium, non-steroidal anti-inflammatory drugs (NSAIDs), etc., so it is crucial to inform your healthcare provider if you are taking other medications. Caution is needed when driving or operating hazardous machinery due to the risk of dizziness or fainting. This medication contains sorbitol, so individuals with fructose intolerance should avoid it. Pregnant women or those planning to become pregnant should not use this medication, and it is also recommended that breastfeeding women avoid it. Children under 18 years of age should not use this medication, as its safety and efficacy have not been established. In case of overdose, there is a risk of hypotension, dizziness, acute renal failure, etc., and immediate contact with medical personnel for appropriate treatment is necessary. This medication should be stored out of reach of children, and the package should not be opened until just before taking it.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness (severe allergic reaction), severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucosa (severe skin reaction), shortness of breath or difficulty breathing, asthma attack, respiratory distress accompanied by cough and fever (respiratory issues), yellowing of skin or eyes (jaundice), extreme fatigue (liver issues (jaundice)), sudden

Mild side effects

Upper respiratory tract infection (including pharyngitis, sinusitis), urinary tract infection, cystitis, anemia, thrombocytopenia, eosinophilia, hypersensitivity, depression, insomnia, anxiety, fainting, drowsiness, visual disturbances, dizziness, bradycardia, tachycardia, hypotension, orthostatic hypotension, cough, abdominal pain, diarrhea, indigestion, abdominal bloating, vomiting, abdominal discomfort, dry mouth, altered taste, increased sweating, pruritus, rash, erythema, drug rash, toxic skin rash, eczema, myalgia

This medication should be stored in a tightly closed container to prevent air or moisture from entering and kept at room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain its effectiveness.

Appearance

White or almost white, double-convex round tablets

Package unit

30 tablets/blister [10 tablets/blister X 3]